JPMorgan Chase & Co. Boosts Stake in Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM)

JPMorgan Chase & Co. increased its holdings in shares of Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM – Free Report) by 224.3% during the fourth quarter, HoldingsChannel reports. The fund owned 264,585 shares of the company’s stock after buying an additional 182,993 shares during the period. JPMorgan Chase & Co.’s holdings in Rhythm Pharmaceuticals were worth $14,811,000 at […]